LAWRENCE, Mass., Jan. 7 /PRNewswire-FirstCall/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced that it has signed a five-year agreement with DaVita, Inc. (NYSE: DVA) to continue to supply DaVita's dialysis centers with MasterGuard and ButtonHole safety needle sets, subject to certain terms and conditions. Safety needles are essential products used to access patients' blood during the vast majority of chronic dialysis therapy treatments. MasterGuard is the leading product in this market, and became part of NxStage's product portfolio through the recent acquisition of Medisystems.
DaVita and its predecessors have a long, successful history with Medisystems brand needles.
"We are very pleased to continue our long-standing relationship as DaVita's primary needle supplier," said Jeffrey H. Burbank, President & CEO of NxStage Medical. "Medisystems' high quality, innovative products was one of the key reasons we acquired the company last year. This new agreement with DaVita solidifies NxStage's position as a dialysis industry leader in-center, as well as in the critical care and home hemodialysis markets."
About NxStage Medical
NxStage Medical, Inc. (Nasdaq: NXTM) is a medical device company,
headquartered in Lawr
|SOURCE NxStage Medical, Inc.|
Copyright©2008 PR Newswire.
All rights reserved